Details of the Drug

General Information of Drug (ID: DM19CFZ)

Drug Name

DIMS-0150

Synonyms

Kappaproct; Antisense NF-kBp65 oligonucleotide (IBD), InDex Pharmaceuticals; Antisense NF-kBp65 oligonucleotide (IBD), Serono; Antisense NF-kBp65 oligonucleotide (inflammatory bowel disease), Serono

Indication

Disease Entry	ICD 11	Status	REF
Ulcerative colitis	DD71	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Antisense drug

Cross-matching ID

TTD ID: D0U1HX

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
NFKB messenger RNA (NFKB mRNA)	TTKLNRV	NFKB2_HUMAN	Not Available	[2]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

MIA Detail

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT01493960) The Efficacy and Safety of Kappaproct in Chronic Active Treatment Refractory Ulcerative Colitis Patients. U.S. National Institutes of Health.
2	News and Analysis. Nature Reviews Drug Discovery 12, 179 (March 2013).